Triple Therapy Outperforms Biologics in RA
Researchers are suggesting the adoption of triple therapy as a first-line treatment after RA patients fail methotrexate monotherapy.
Does your patient suffer from kinesiophobia?
Kinesiophobia, or the fear of movement, may keep knee osteoarthritis patients from physical therapy and by consequence, recovery.
Spinal Manipulative Therapy May Offer Pain Relief
Despite clinical evidence, patients are seeking chiropractic care for back pain. This study shows there may be some merit in the practice.
Lymphoma Rates in RA Unchanged Despite TNFi Therapy
Malignant lymphoma proves to be a difficult adversary in rheumatoid arthritis, despite TNFi therapy, a study shows.
Melanoma Risk in Rheumatoid Arthritis Refuted
A large international study shows there is no increased risk of melanoma in rheumatoid arthritis disproving previous analyses.
Evaluating Organ Systems in Lupus
LFA-REAL offers a straight-forward evaluation for lupus-affected organ systems, a study shows.
Anifrolumab for Lupus
Anifrolumab, a type 1 interferon receptor antagonist, performs well in early trial, researchers show.
By clicking Accept, you agree to become a member of the UBM Medica Community.